RUNX1 germline variants in RUNX1-mutant AML: how frequent?
- 11 March 2021
- journal article
- letter
- Published by American Society of Hematology in Blood
- Vol. 137 (10), 1428-1431
- https://doi.org/10.1182/blood.2020008478
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AMLBlood, 2020
- ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variantsBlood Advances, 2019
- Molecular Minimal Residual Disease in Acute Myeloid LeukemiaThe New England Journal of Medicine, 2018
- Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignanciesBlood Advances, 2018
- Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AMLBlood, 2017
- RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic featuresLeukemia, 2016
- RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression SignaturesJournal of Clinical Oncology, 2012
- RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genesHaematologica, 2012
- RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosisBlood, 2011
- AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterationsBlood, 2009